Target intelligence / Profile preview

Polycomb group RING finger protein 5 (PCGF5)

Target
PCGF5
Molecular classification
Polycomb-group protein, Epigenetic regulator, Transcription factor (repressor/activator), RING finger protein, Component of Polycomb repressive complex 1.5 (PRC1.5)
01

Overview

Polycomb group RING finger protein 5 (PCGF5) is a member of the Polycomb-group (PcG) family of proteins, functioning primarily as a core component of the Polycomb repressive complex 1.5 (PRC1.5), which is involved in epigenetic regulation and maintenance of the transcriptionally repressive state of target genes[1][2][3][5][6]. PCGF5 has essential roles in embryonic stem cell pluripotency, lineage commitment, and the regulation of key developmental signaling pathways such as Nodal, Wnt, and Notch during early development[1][2][3]. Loss of PCGF5 disrupts proper differentiation of embryonic stem cells, especially affecting the formation of ectoderm, and alters epithelial-mesenchymal transition processes[1][3]. Although PCGF5 shares many canonical Polycomb group functions (gene silencing and maintenance of chromatin states), there is evidence it can act as a transcriptional activator under certain conditions by interacting with co-activators such as Tex10 and p300[2]. PCGF5 is not currently recognized as a direct therapeutic target or as having defined drug interactions. As with other Polycomb proteins, abnormal regulation of PCGF5 is likely to play a role in disease, particularly those associated with aberrant epigenetic regulation and development[2][3][4].

Other names
PCGF5RNF159Polycomb group ring finger 5RING finger protein 159
02

Biological functions

Epigenetic transcriptional repressionRegulation of gene expression during developmentMaintenance of stem cell state and pluripotencyModulation of developmental signaling pathways (Nodal, Wnt, Notch)Regulation of epithelial-mesenchymal transitionDifferentiation of embryonic stem cells
03

Disease associations

Cancer (by analogy to other Polycomb proteins, but direct evidence for PCGF5 is limited)Developmental disorders (inferred from its role in embryonic development)Other (specifically, defects cause developmental delays at cellular level)

Beyond the preview

Go deeper on Polycomb group RING finger protein 5 (PCGF5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polycomb group RING finger protein 5 (PCGF5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call